| Brentuximab vedotin: an anti-CD30 antibody–drug conjugate AM Bradley, M Devine, D DeRemer American Journal of Health-System Pharmacy 70 (7), 589-597, 2013 | 52 | 2013 |
| Development and implementation of a writing program to improve resident authorship rates AB Clemmons, SC Hoge, A Cribb, KB Manasco American Journal of Health-System Pharmacy 72 (17_Supplement_2), S53-S57, 2015 | 24 | 2015 |
| Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients ME Hartranft, AB Clemmons, DL DeRemer, V Kota Journal of Oncology Pharmacy Practice 23 (1), 10-17, 2017 | 21 | 2017 |
| Successful use of intrathecal carboxypeptidase G2 for intrathecal methotrexate overdose: a case study and review of the literature AM Bradley, LW Buie, A Kuykendal, PM Voorhees Clinical Lymphoma Myeloma and Leukemia 13 (2), 166-170, 2013 | 20 | 2013 |
| Survey of learning opportunities in academia for pharmacy residents KB Manasco, AM Bradley, TA Gomez American Journal of Health-System Pharmacy 69 (16), 1410-1414, 2012 | 20 | 2012 |
| Neutropenia‐Associated Outcomes in Adults with Acute Myeloid Leukemia Receiving Cytarabine Consolidation Chemotherapy with or without Granulocyte Colony‐Stimulating Factor AM Bradley, AM Deal, LW Buie, H van Deventer Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (12 …, 2012 | 17 | 2012 |
| Romiplostim resistance in secondary failure of platelet recovery DL DeRemer, K Katsanevas, A Bradley, FT Awan Journal of Oncology Pharmacy Practice 19 (4), 369-372, 2013 | 12 | 2013 |
| Busulfan dosing (Q6 or Q24) with adjusted or actual body weight, does it matter? AB Clemmons, S Evans, DL DeRemer, FT Awan Journal of Oncology Pharmacy Practice 21 (6), 425-432, 2015 | 8 | 2015 |
| Converting to transdermal fentanyl: avoidance of underdosing AM Bradley, JM Valgus, S Bernard Journal of Palliative Medicine 16 (4), 409-411, 2013 | 6 | 2013 |
| Impact of Fluoroquinolone Prophylaxis on Infectious Related Outcomes after Hematopoietic Cell Transplantation: A Single-Center Experience AB Clemmons, B Albrecht, AS Gandhi, S Jacobson, J Pantin Biology of Blood and Marrow Transplantation 22 (3), S474-S475, 2016 | 3 | 2016 |
| Application of opioid analgesia concepts in a third-year pharmacy student skills laboratory on three campuses MW Neville, AB Clemmons, CS Hunter Journal of Pain & Palliative Care Pharmacotherapy 28 (1), 10-18, 2014 | 3 | 2014 |
| Impact of Fluoroquinolone Prophylaxis on Survival Outcomes after Hematopoietic Stem Cell Transplantation: A Single-Center Experience S Jacobson, AB Clemmons, A Shah, B Albrecht, C Sportes, L Bryan, ... Biology of Blood and Marrow Transplantation 22 (3), S167-S168, 2016 | 2 | 2016 |
| Implementation of an individualized argatroban protocol in an academic medical center AM Bradley, T Branan American Journal of Health-System Pharmacy 68 (14), 1292-1293, 2011 | 1 | 2011 |
| Fosaprepitant for the Prevention of Nausea and Vomiting in Patients Receiving BEAM or High-Dose Melphalan Conditioning Regimens for Autologous Hematopoietic Stem Cell … SM Clark, L Schaack, D DeRemer, V Kota, AB Clemmons Biology of Blood and Marrow Transplantation 20 (2), S287, 2014 | | 2014 |
| Administration of Rabbit Anti-Thymocyte Globulin: Slowing Infusion Rate over a 4 Day Course with Aggressive Use of Pre-Medications May Decrease ATG Related Infusion Reactions AB Clemmons, ME Hartranft, V Kota, J Pantin, FT Awan, H Salman, ... Biology of Blood and Marrow Transplantation 20 (2), S287-S288, 2014 | | 2014 |
| Intravenous Busulfan Pharmacokinetics in Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Dosing Weight AM Bradley, S Evans, D DeRemer, FT Awan Biology of Blood and Marrow Transplantation 19 (2), S373-S374, 2013 | | 2013 |
